BioCentury
ARTICLE | Company News

Astellas exercises option to acquire Potenza

December 21, 2018 7:30 PM UTC

Astellas Pharma Inc. (Tokyo:4503) exercised an exclusive option under an April 2015 deal and acquired Potenza Therapeutics Inc. (Cambridge, Mass.) (see "Potenza Therapeutics, Astellas Deal").

Potenza received $164.6 million up front and is eligible to receive $240.1 million in milestones...